Unified, holistic medical data collection and analysis platform

Informacje na temat projektu

UNITY

Identyfikator umowy o grant: 868266

DOI

10.3030/868266

Projekt został zamknięty

Data podpisania przez KE 30 Kwietnia 2019

Data rozpoczęcia 1 Maja 2019

Data zakończenia 31 Sierpnia 2019

Finansowanie w ramach

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Koszt całkowity

€ 71 429,00

Wkład UE

€ 50 000,00

Koordynowany przez

RAYLYTIC GMBH
Germany

Periodic Reporting for period 1 - UNITY (Unified, holistic medical data collection and analysis platform)

Okres sprawozdawczy: 2019-05-01 do 2019-08-31

Podsumowanie kontekstu i ogólnych celów projektu

UNITY is a cloud-based platform that combines modules for clinical trial management, electronic data capture of patient reported and treatment outcomes, and semi-automated medical image analysis. Its image analysis module can assess the performance of orthopedic implants and detect and quantify musculoskeletal conditions with an accuracy superior to human radiologists. However, we are constrained by our semi-automatic way of processing medical images. Once we develop a fully automated platform, it will be able to perform in seconds tasks that now may take up to one week. With individual modules already on the market and a prototype of the UNITY platform in place, our technology is at TRL 6.

Prace wykonane od początku projektu do końca okresu sprawozdawczego oraz najważniejsze dotychczasowe rezultaty

The feasibility study was conducted to validate our idea of deploying UNITY as fully automated platform for assessment of musculoskeletal conditions. We assessed the technical requirements and prepared a work plan that served as basis for estimating the resources and time needed to complete the project. We also performed a comprehensive analysis of the market, including competition, challenges and trends, freedom to operate and size of the market opportunity. Finally, we developed a business plan for its commercialization; it outlines the strategy to grow our market share and customer base, as well as tentative pricing and revenue models.

Innowacyjność oraz oczekiwany potencjalny wpływ (w tym dotychczasowe znaczenie społeczno-gospodarcze i szersze implikacje społeczne projektu)

The expected impact of the Accelerator grant to our company is very high: we project revenues growing up to €26.4 million in the first 5 commercialization years. We also forecast a growth from 25 to 54 employees and a return on investment of 5.7 by the end of 5th commercialization year.
Our platform offers a unique opportunity for more accurate, personalized treatments. This can result in savings and optimization of workflows for healthcare providers and medtech companies, currently challenged with increasing regulatory constraints. It can also improve the quality of care benefiting both, the patients and the economy.

image-1.png